Deroose JP - Search Results

1

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.

Deroose JP, Grünhagen DJ, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C. Deroose JP, et al. Br J Surg. 2011 Nov;98(11):1573-80. doi: 10.1002/bjs.7621. Epub 2011 Jul 8. Br J Surg. 2011. PMID: 21739427

2

Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?

Deroose JP, Burger JW, van Geel AN, den Bakker MA, de Jong JS, Eggermont AM, Verhoef C. Deroose JP, et al. Ann Surg Oncol. 2011 Feb;18(2):321-7. doi: 10.1245/s10434-010-1400-x. Epub 2010 Nov 4. Ann Surg Oncol. 2011. PMID: 21049306 Free PMC article.

3

Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.

Deroose JP, Eggermont AM, van Geel AN, Verhoef C. Deroose JP, et al. Curr Opin Oncol. 2011 Mar;23(2):183-8. doi: 10.1097/CCO.0b013e3283424dbc. Curr Opin Oncol. 2011. PMID: 21150602 Review.

4

Local and intralesional therapy of in-transit melanoma metastases.

Testori A, Faries MB, Thompson JF, Pennacchioli E, Deroose JP, van Geel AN, Verhoef C, Verrecchia F, Soteldo J. Testori A, et al. Among authors: deroose jp. J Surg Oncol. 2011 Sep;104(4):391-6. doi: 10.1002/jso.22029. J Surg Oncol. 2011. PMID: 21858834 Review.

5

20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters.

Deroose JP, Eggermont AM, van Geel AN, de Wilt JH, Burger JW, Verhoef C. Deroose JP, et al. Ann Surg Oncol. 2012 Feb;19(2):627-35. doi: 10.1245/s10434-011-2030-7. Epub 2011 Aug 31. Ann Surg Oncol. 2012. PMID: 21879272 Free PMC article.

6

Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.

Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, Verhoef C. Deroose JP, et al. J Clin Oncol. 2011 Oct 20;29(30):4036-44. doi: 10.1200/JCO.2011.35.6618. Epub 2011 Sep 19. J Clin Oncol. 2011. PMID: 21931039

7

Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients.

Deroose JP, van Geel AN, Burger JW, Eggermont AM, Verhoef C. Deroose JP, et al. J Surg Oncol. 2012 May;105(6):563-9. doi: 10.1002/jso.22121. Epub 2011 Oct 21. J Surg Oncol. 2012. PMID: 22020863

8

Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis.

van Broekhoven DL, Deroose JP, Bonvalot S, Gronchi A, Grünhagen DJ, Eggermont AM, Verhoef C. van Broekhoven DL, et al. Among authors: deroose jp. Br J Surg. 2014 Dec;101(13):1674-80. doi: 10.1002/bjs.9659. Epub 2014 Oct 9. Br J Surg. 2014. PMID: 25296896

9

Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas.

Deroose JP, Grünhagen DJ, de Wilt JH, Eggermont AM, Verhoef C. Deroose JP, et al. Eur J Cancer. 2015 Feb;51(3):367-73. doi: 10.1016/j.ejca.2014.11.020. Epub 2014 Dec 16. Eur J Cancer. 2015. PMID: 25529370

10

Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.

Deroose JP, Grünhagen DJ, Eggermont AM, Verhoef C. Deroose JP, et al. Melanoma Res. 2015 Oct;25(5):427-31. doi: 10.1097/CMR.0000000000000177. Melanoma Res. 2015. PMID: 26110555 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters